Buscar | Faith World Co

Sagareshital Sagareshital agregó una foto Health
2025-12-26 09:00:44 -

Rituximab Market Forecast: Future Trends and Opportunities
The Rituximab Market forecast is promising, driven by the increasing prevalence of autoimmune disorders and hematologic cancers globally. Rising adoption of biosimilars is making treatment more affordable, expanding the Rituximab Market Demands across diverse patient populations. North America continues to dominate in terms of Rituximab Market Share, while Asia-Pacific and Latin America...

0 Commentarios 0 Acciones 38 Views 0 Vista previa

Please log in to like, share and comment!
Pratiksha Dhote agregó una foto Health
2026-04-15 11:54:46 -

The cancer drug that changed everything: why Rituximab is still a blockbuster after 25 years
First approved in 1997, Rituximab (Rituxan) was the first monoclonal antibody for cancer. It targets CD20 on B-cells, killing lymphoma cells while sparing healthy tissue. The rituximab market report by MRFR shows that non-Hodgkin lymphoma (NHL) is the largest indication, but chronic lymphocytic leukemia (CLL) is the fastest‑growing. The market is $34.52 billion and will hit $52.37...

0 Commentarios 0 Acciones 3 Views 0 Vista previa

Please log in to like, share and comment!